Intestinal permeability of oxytetracycline from chitosan-montmorillonite nanocomposites

被引：34

作者：

Salcedo, Inmaculada ^{[1
]}

Sandri, Giuseppina ^{[2
]}

La Aguzzi, Caro ^{[1
]}

Bonferoni, Cristina ^{[2
]}

Cerezo, Pilar ^{[1
]}

Sanchez-Espejo, Rita ^{[3
]}

Viseras, Cesar ^{[1
,3
]}

机构：

[1] Univ Granada, Sch Pharm, Dept Pharm & Pharmaceut Technol, Granada, Spain

[2] Univ Pavia, Dept Drug Sci, I-27100 Pavia, Italy

[3] Univ Granada, CSIC, Andalusian Inst Earth Sci, Granada 18100, Spain

来源：

COLLOIDS AND SURFACES B-BIOINTERFACES | 2014年 / 117卷

关键词：

Oxytetracycline; Caco-2; Nanocomposites; Montmorillonite; Chitosan; BIOPOLYMER-CLAY NANOCOMPOSITES; EXCISED RAT JEJUNUM; CACO-2; CELLS; DRUG-DELIVERY; ORAL DELIVERY; NANOPARTICLES; ABSORPTION; DERIVATIVES; PHARMACOKINETICS; SPECTROSCOPY;

D O I：

10.1016/j.colsurfb.2013.11.009

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

A nanocomposite based on chitosan and montmorillonite was developed as carrier to improve oral bioavailability of oxytetracycline. The nanocomposite was prepared by simple solid-liquid interaction and loaded with the drug. The loaded nanocomposite was characterized by X-ray powder diffraction, thermal analysis, FTIR spectroscopy and zeta potential. Caco-2 cell cultures were used to evaluate in vitro cytotoxicity and drug permeation. Confocal laser scanning microscopy was also performed to evaluate the eventual entrapment of drug into the Caco-2 cells. Results showed that the nanocomposite was internalized into the cells and effectively enhanced drug permeation, being also biocompatible towards Caco-2 cells. (C) 2013 Elsevier B.V. All rights reserved.

引用

页码：441 / 448

页数：8

共 49 条

[1] Influence of dispersion conditions of two pharmaceutical grade clays on their interaction with some tetracyclines [J].

Aguzzi, C ;

Viseras, C ;

Cerezo, P ;

Rossi, S ;

Ferrari, F ;

López-Galindo, A ;

Caramella, C .

APPLIED CLAY SCIENCE, 2005, 30 (02) :79-86

[2] Assessement of anti-inflammatory properties of microspheres prepared with chitosan and 5-amino salicylic acid over inflamed Caco-2 cells [J].

Aguzzi, C. ;

Ortega, A. ;

Bonferoni, M. C. ;

Sandri, G. ;

Cerezo, P. ;

Salcedo, I. ;

Sanchez, R. ;

Viseras, C. ;

Caramella, C. .

CARBOHYDRATE POLYMERS, 2011, 85 (03) :638-644

[3] Chitosan-silicate biocomposites to be used in modified drug release of 5-aminosalicylic acid (5-ASA) [J].

Aguzzi, C. ;

Capra, P. ;

Bonferoni, C. ;

Cerezo, P. ;

Salcedo, I. ;

Sanchez, R. ;

Caramella, C. ;

Viseras, C. .

APPLIED CLAY SCIENCE, 2010, 50 (01) :106-111

[4] Caco-2 monolayers in experimental and theoretical predictions of drug transport (Reprinted from Advanced Drug Delivery Reviews, vol 22, pg 67-84, 1996) [J].

Artursson, P ;

Palm, K ;

Luthman, K .

ADVANCED DRUG DELIVERY REVIEWS, 2001, 46 (1-3) :27-43

[5]

Ashford M, 2007, AULTONS PHARM, P270

[6] Comparison of drug transporter levels in normal colon, colon cancer, and Caco-2 cells: Impact on drug disposition and discovery [J].

Calcagno, Anna Maria ;

Ludwig, Joseph A. ;

Fostel, Jennifer M. ;

Gottesman, Michael M. ;

Ambudkar, Suresh V. .

MOLECULAR PHARMACEUTICS, 2006, 3 (01) :87-93

[7] Chitosan and its derivatives as drug penetration enhancers [J].

Caramella, C. ;

Ferrari, F. ;

Bonferoni, M. C. ;

Rossi, S. ;

Sandri, G. .

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2010, 20 (01) :5-13

[8] Regulated portals of entry into the cell [J].

Conner, SD ;

Schmid, SL .

NATURE, 2003, 422 (6927) :37-44

[9] THE INFRA-RED SPECTRA OF SOME INORGANIC PHOSPHORUS COMPOUNDS [J].

CORBRIDGE, DEC ;

LOWE, EJ .

JOURNAL OF THE CHEMICAL SOCIETY, 1954, (FEB) :493-502

[10] Biopolymer-clay nanocomposites based on chitosan intercalated in montmorillonite [J].

Darder, M ;

Colilla, M ;

Ruiz-Hitzky, E .

CHEMISTRY OF MATERIALS, 2003, 15 (20) :3774-3780

← 1 2 3 4 5 →